Cover Story Archives
Tennessee, already an automotive powerhouse, motors into our winner’s circle with a diverse growth strategy that’s hitting on all cylinders.
Many locations are gaining an advantage in the battle for new projects with pre-certification programs for available sites. From the September/October 2013 issue.
Our 9th annual report card of the state, metro and international pecking order features more than 50 rankings categories, including new energy rankings and a close look at which locations are maintaining/upgrading critical infrastructure. From the July/August 2013 issue.
Baton Rouge tops the field in economic growth potential; China surges into the lead in renewable energy investment. From the July/August 2013 issue.
From the digitization of equipment and processes to 3D printing to materials with custom-designed properties, advanced manufacturing is driving high-tech innovation, exports and the creation on high-wage jobs. From the May/June 2013 issue.
As the global financial system continues to mend, venture capital is beginning to flow back into the biotechnology sector. In Europe, the largest biomed players are thriving, while entrepreneurial biotech start-ups gain traction in the U.S. From the March/April 2013 issue.
Baxter International’s decision to make a $1.3-billion investment in an expansion of its bio/pharmaceutical manufacturing promises to propel the Peach State into the front ranks of national biotech powerhouses. From the January/February 2013 issue.
We deployed our growth detector to winnow the field for our annual showcase of leading locations. As usual, making the picks was harder than singing their praises, as all of the finalists were worthy. From the September/October 2012 issue
It’s time for our annual exercise, separating wheat from chaff in the fertile fields of development. As always, our rankings point to growth potential. But in a struggling economy, we’re also giving extra credit for real jobs. From the July/August 2012 issue
The global financial contraction put a squeeze on seed money for biotech startups, forcing locations to build their biotech future the old-fashioned way: with long-term planning and a comprehensive strategy for growth. From the May/June 2012 issue.